{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:17:02Z","timestamp":1770970622085,"version":"3.50.1"},"reference-count":20,"publisher":"Royal College of Psychiatrists","issue":"5","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"unspecified","delay-in-days":12142,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1984,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Of 603 patients receiving in-patient or day-patient psychiatric care, one-sixth were taking no psychotropic drugs, but nearly 50% of those receiving medication had a combination of two or more such drugs. Hypnotics and minor tranquillisers were frequently prescribed together with neuroleptics and antidepressants. One-third of all patients receiving neuroleptics received a combination of oral and depot preparations, while half of all patients on neuroleptics were prescribed anti-parkinsonian drugs. One-fifth of patients treated with neuroleptics had a diagnosis other than schizophrenia, and one-third of patients treated with antidepressants had a diagnosis other than affective disorder. A comparison of our findings with those from Oxford show some significant differences, particularly in the use of depot, oral, of combined neuroleptic drugs. An analysis of prescribing could be a useful part of self-audit for hospitals.<\/jats:p>","DOI":"10.1192\/bjp.145.5.502","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T23:20:52Z","timestamp":1218583252000},"page":"502-507","source":"Crossref","is-referenced-by-count":54,"title":["A Survey of Prescribing of Psychotropic Drugs in a Birmingham Psychiatric Hospital"],"prefix":"10.1192","volume":"145","author":[{"given":"Stephen","family":"Edwards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"S0007125000118884_ref4","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700047942"},{"key":"S0007125000118884_ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1971.01750170026005"},{"key":"S0007125000118884_ref7","unstructured":"Marks J. (1977) The doctor, the patient and psychotropic drugs. Update, May, 1195\u20131200."},{"key":"S0007125000118884_ref20","article-title":"Importance of akinesia: plasma chlorpromazine and prolactin levels","volume":"137","author":"Van Putten","year":"1980","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000118884_ref1","article-title":"Peer review of prescribing pattern in a CMHC","volume":"133","author":"Diamond","year":"1976","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000118884_ref12","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.135.6.509"},{"key":"S0007125000118884_ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770340115014"},{"key":"S0007125000118884_ref19","article-title":"\u2018Akinetic depression\u2019 in schizophrenia","volume":"35","author":"Van Putten","year":"1980","journal-title":"Archives of General Psychiatry"},{"key":"S0007125000118884_ref9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.124.2.151"},{"key":"S0007125000118884_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1975.tb01576.x"},{"key":"S0007125000118884_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1976.tb00577.x"},{"key":"S0007125000118884_ref11","first-page":"49","article-title":"What influences have led to an increased prescribing of psychotropic drugs?","volume":"23","author":"Parish","year":"1973","journal-title":"Journal of the Royal College of General Practitioners"},{"key":"S0007125000118884_ref13","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.140.5.470"},{"key":"S0007125000118884_ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770280093010"},{"key":"S0007125000118884_ref16","article-title":"Polypharmacy in psychiatric treatment: 1. Incidence at a state hospital","volume":"11","author":"Sheppard","year":"1969","journal-title":"Current Therapeutic Research"},{"key":"S0007125000118884_ref17","article-title":"Polypharmacy in psychiatry: patterns of differential treatment","volume":"126","author":"Skippard","year":"1970","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000118884_ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6143.1008"},{"key":"S0007125000118884_ref8","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.138.3.217"},{"key":"S0007125000118884_ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750220084016"},{"key":"S0007125000118884_ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1977.tb06676.x"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000118884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T19:28:12Z","timestamp":1558639692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000118884\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1984,11]]}},"alternative-id":["S0007125000118884"],"URL":"https:\/\/doi.org\/10.1192\/bjp.145.5.502","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,11]]}}}